CHF 150k · Other round · Healthtech · Uster, Switzerland
RheoCarti has received CHF 150,000 from Venture Kick to advance a new class of orthopaedic implants that pair a load-bearing titanium structure with a cartilage-like hydrogel surface. The Uster-based ETH Zurich project will use the support to strengthen its team, improve manufacturing readiness and develop the market ahead of its first veterinary clinical applications.
Rebuilding the joint surface, not only replacing it
Conventional joint implants restore mobility, but their hard bearing surfaces do not reproduce the low friction and shock absorption of natural cartilage. RheoCarti's biomimetic design combines titanium with a hydrogel-on-hydrogel articulating surface intended to provide smoother movement and better damping, particularly for younger and more active patients who may place an implant under decades of repeated load.
The technology emerged from ETH Zurich's Laboratory for Orthopedic Technology and is being developed by Dr Xiaoyu Du with Prof Stephen Ferguson as scientific adviser. Venture Kick describes the implant as patent pending. RheoCarti's initial products are a hip-resurfacing implant and a total hip-replacement system, while the company says the underlying platform could later extend to knees, shoulders and spinal applications.
Veterinary use is the first translation test
RheoCarti plans to enter veterinary orthopaedics before pursuing human joint replacement. That sequence gives the company a defined first market in which to test whether its laboratory material performance can become a consistent manufactured implant and produce useful clinical outcomes. It does not remove the evidence burden: durability, repeatable production and performance in surgery remain the milestones that will determine whether the technology can progress beyond preclinical development.
The CHF 150,000 award is therefore translation capital rather than scale-up funding. It supports the practical work between a promising material system and initial clinical use, while the veterinary route can generate manufacturing and deployment experience for the longer-term human programme. The next proof point is not simply making more prototypes, but showing that the cartilage-like surface retains its mechanical advantages in a product surgeons can use reliably.
Sources checked:
Startupticker · ETH Entrepreneurship · Venture Kick · RheoCarti · Tech.eu Funding Explorer
